Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
This article was originally published in The Tan Sheet
Executive Summary
No available evidence demonstrates that consumer antiseptic products reduce the risk of skin infection and such indications should not be included in the drug monograph, Office of Nonprescription Products reviewers say
You may also be interested in...
Antibiotics, Not Antimicrobials, To Blame For Resistant Bacteria – SDA
Attacks on antimicrobial soap and other products for an alleged link to antibiotic resistance divert attention from the primary cause of the problem - the over-prescription of antibiotic drugs, according to the Soap and Detergent Association
DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph
Trade Group Calls For “Reasoned Discussions” On Triclocarban Research
The Soap & Detergent Association is asking for "reasoned discussions" of new research on the topical antiseptic ingredient triclocarban using "realistic risk assessment scenarios, rather than casual observations which can lead to distorted headlines and misleading conclusions," in a statement released May 25